MedPath

Extensive Mesenteric Excision (EME) Versus Local Mesenteric Excision (LME) for Crohn's Disease

Not Applicable
Completed
Conditions
Postoperative Disease Recurrence
Crohns Disease
Interventions
Procedure: mesenteric excision
Registration Number
NCT02542904
Lead Sponsor
Jinling Hospital, China
Brief Summary

Crohn's patients receiving ileocolonic resection are randomized into extensive mesenteric resection group and local mesenteric resection group.

Detailed Description

Randomization was performed intraoperatively once the surgeon had determined that there were no other sites of disease and that either type of anastomosis could be performed safely. Computer generated randomization was carried out within strata using randomized permuted blocks to ensure balance of the groups.

All surgery was performed by a single group of surgeons experienced in the surgical treatment of Crohn's disease. Surgery was performed open or laparoscopically depending on patient factors and surgeon preference. The resection was performed grossly normal resection margins, with side-to-side anastomosis. The presence of mesenteric marginal thickening with confirmation by naked eye assessment of the mucosal aspect of the bowel were used to establish the limits of the disease.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
119
Inclusion Criteria
  • Crohn's disease limited to the distal ileum and/or right colon
Exclusion Criteria
  • Concomitant anastomosis/strictureplasty at another site of the gastrointestinal tract, and required a temporary fecal diversion

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
EMEmesenteric excisionthe anastomosis was performed as a stapled side-to-side anastomosis with extensive excision of mesenteric tissue.
LMEmesenteric excisionthe anastomosis was performed as stapled side-to-side with local excision of the mesenteric tissue adjacent to the diseased bowel
Primary Outcome Measures
NameTimeMethod
postoperative endoscopic recurrence12 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Jinling Hospital

🇨🇳

Nanjing, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath